Autopsy report · NCT04880382

Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients

“Enrolment was slowlier than expected.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 4 years 6 months before it stopped.
• 8 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Institut Bergonié

Sponsor type

University, hospital or other

Conditions

Non Small Cell Lung Cancer

Interventions

ICI treatment discontinuation; ICI treatment continuation

Participants

8

Sites

5

Countries

France

Trials that died the same way

• Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure
  “Slow enrolment.” (84% match in meaning)
• Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance
  “Due to slow enrolment” (76% match in meaning)
• IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population
  “Participant enrolment was lower than expected” (67% match in meaning)
• Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor
  “Too low enrolment rate” (66% match in meaning)
• Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer
  “Low enrolment rate” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.